Mostrar el registro sencillo del ítem

dc.contributor.authorBravo López, Susana Belén
dc.contributor.authorRodríguez García-Rendueles, María E
dc.contributor.authorRodríguez García-Rendueles, Ángela
dc.contributor.authorSousa Rodrigues, Joana
dc.contributor.authorPérez Romero, Sihara
dc.contributor.authorGarcía Lavandeira, Montserrat
dc.contributor.authorSuárez Fariña, María
dc.contributor.authorBarreiro Morandeira, Francisco 
dc.contributor.authorCzarnocka, B.
dc.contributor.authorSenra ?, Ana
dc.contributor.authorLareu Huidobro, María Victoria
dc.contributor.authorRodríguez García, Javier 
dc.contributor.authorCameselle Teijeiro, Jose Manuel 
dc.contributor.authorÁlvarez Villamarín, Clara
dc.date.accessioned2017-06-07T07:02:28Z
dc.date.available2017-06-07T07:02:28Z
dc.date.issued2013
dc.identifier.issn0021-972X
dc.identifier.urihttp://hdl.handle.net/20.500.11940/1954
dc.description.abstractMechanisms of thyroid physiology and cancer are principally studied in follicular cell lines. However, human thyroid cancer lines were found to be heavily contaminated by other sources, and only one supposedly normal-thyroid cell line, immortalized with SV40 antigen, is available. In primary culture, human follicular cultures lose their phenotype after passage. We hypothesized that the loss of the thyroid phenotype could be related to culture conditions in which human cells are grown in medium optimized for rodent culture, including hormones with marked differences in its affinity for the relevant rodent/human receptor.|The objective of the study was to define conditions that allow the proliferation of primary human follicular thyrocytes for many passages without losing phenotype.|Concentrations of hormones, transferrin, iodine, oligoelements, antioxidants, metabolites, and ethanol were adjusted within normal homeostatic human serum ranges. Single cultures were identified by short tandem repeats. Human-rodent interspecies contamination was assessed.|We defined an humanized 7 homeostatic additives medium enabling growth of human thyroid cultures for more than 20 passages maintaining thyrocyte phenotype. Thyrocytes proliferated and were grouped as follicle-like structures; expressed Na+/I- symporter, pendrin, cytokeratins, thyroglobulin, and thyroperoxidase showed iodine-uptake and secreted thyroglobulin and free T3. Using these conditions, we generated a bank of thyroid tumors in culture from normal thyroids, Grave's hyperplasias, benign neoplasms (goiter, adenomas), and carcinomas.|Using appropriate culture conditions is essential for phenotype maintenance in human thyrocytes. The bank of thyroid tumors in culture generated under humanized humanized 7 homeostatic additives culture conditions will provide a much-needed tool to compare similarly growing cells from normal vs pathological origins and thus to elucidate the molecular basis of thyroid disease.
dc.description.sponsorshipMinisterio de Ciencia e Innovación
dc.description.sponsorshipInstituto de Salud Carlos III
dc.description.sponsorshipXunta de Galicia
dc.description.sponsorshipFondo Social Europeo of the European Community
dc.language.isoeng
dc.subject.meshAnimals
dc.subject.meshCell Culture Techniques
dc.subject.meshCell Line, Tumor
dc.subject.meshCell Proliferation
dc.subject.meshCulture Media
dc.subject.meshHumans
dc.subject.meshPhenotype
dc.subject.meshRats
dc.subject.meshThyroglobulin
dc.subject.meshThyroid Gland
dc.subject.meshThyroid Neoplasms
dc.subject.meshTriiodothyronine
dc.titleHumanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroid, benign neoplasm, and cancer
dc.typeArtigoes
dc.authorsophosBravo, S. B.
dc.authorsophosGarcia-Rendueles, M. E.
dc.authorsophosGarcia-Rendueles, A. R.
dc.authorsophosRodrigues, J. S.
dc.authorsophosPerez-Romero, S.
dc.authorsophosGarcia-Lavandeira, M.
dc.authorsophosSuarez-Fariña, M.
dc.authorsophosBarreiro, F.
dc.authorsophosCzarnocka, B.
dc.authorsophosSenra, A.
dc.authorsophosLareu, M. V.
dc.authorsophosRodriguez-Garcia, J.
dc.authorsophosCameselle-Teijeiro, J.
dc.authorsophosAlvarez, C. V.
dc.identifier.doi10.1210/jc.2012-3812
dc.identifier.isi319736500050
dc.identifier.pmid23539720
dc.identifier.sophos12455
dc.issue.number6
dc.journal.titleJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Análise clínicos
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Anatomía Patolóxica
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Cirurxía Xeral e dixestiva
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::NeurofisioloxíaClínica
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago
dc.page.initial2431
dc.page.final41
dc.relation.projectIDFondo Social Europeo of the European Community/BFU2010-16652
dc.relation.projectIDFondo Social Europeo of the European Community/09CSA011208PR
dc.relation.projectIDFondo Social Europeo of the European Community/2012PG201
dc.relation.projectIDFondo Social Europeo of the European Community/09CSA020208PR
dc.relation.projectIDFondo Social Europeo of the European Community/PS09/02050
dc.relation.publisherversionhttps://academic.oup.com/jcem/article-pdf/98/6/2431/10423309/jcem2431.pdf
dc.rights.accessRightsopenAccess
dc.typesophosArtículo Original
dc.volume.number98


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem